A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
01/2003
01/01/2003	CN1097466C Living salmonella vaccine
01/01/2003	CN1097452C Skin spraying sterilizing agent
12/2002
12/31/2002	US6500945 Nucleotides having chiral phosphorus linkages
12/31/2002	US6500936 Glycerol culture of actinomyces
12/31/2002	US6500863 Interleukin binding inhibitors such as n-(2-hydroxyl-3-amino sulfonyl-4-chlorophenyl)-n'-(2-bromophenyl)urea, used for prophylaxis of chemokine mediated diseases
12/31/2002	US6500856 For therapy of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators
12/31/2002	US6500842 N-((4-chlorophenyl)methyl)-8-hydroxy-7-quinolinecarboxamide administered as viricides against herpes virus
12/31/2002	US6500832 Administering enzyme inhibitors as viricides for prophylaxis of viral diseases such as aquired immune deficiency syndrome
12/31/2002	US6500823 Energy deficiency of the cell caused by parp inhibition, in diabetes complications, in oxygen deficient status of the heart and brain, in neurodegenerative diseases, in the treatment of autoimmune and/or viral diseases
12/31/2002	US6500817 Thiazolyl urea derivatives and their utilization as antiviral agents
12/31/2002	US6500811 Prophylaxis and therapy of disorders in the course of which an increased activity of matrix-degrading enzymes is involved; these include degenerative joint disorders such as osteoarthroses and disorders of connective tissue
12/31/2002	US6500804 Administering a dipeptidyl aminopeptidase effector which is selected from the group consisting of n-(n-substituted glycyl)2-cyanopyrrolidones, n-aminoacyl thiazolidines, n-aminoacyl pyrrolidines
12/31/2002	US6500662 Infectious cdna clones of positive polarity rna viruses and the construction of vaccines, in particular, swine vaccines, using such cdna clones
12/31/2002	US6500641 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide encoding a cell binding element,
12/31/2002	US6500613 Isolated pneumococcal surface protein c, pspc, of strepto-coccus pneumoniae having alpha-helical, proline rich and repeat regions
12/31/2002	US6500467 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
12/31/2002	US6500466 Chlorhexidine formulations, new chlorhexidine salts, solutions containing these and their use
12/31/2002	US6500460 Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention, and an applicator for the delivery of topical formulations into mucosal cavities
12/31/2002	US6500438 In ovo vaccination against coccidiosis
12/31/2002	US6500424 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
12/31/2002	US6500423 Probiotic composition comprising viable escherichia coli strain bu-230-98 atcc deposit no. 20226 (dsm 12799) and a formulation for maintaining viability of said escherichia coli strain
12/31/2002	US6500409 Oral antigingivitis composition comprising an orally acceptable vehicle of a combination of a noncationic halogenated hydroxydiphenyl ether and an extract of magnolia cortex, the bark of magnolia officinalis such as magnolol
12/31/2002	CA2227814C Substituted benzylaminopiperidine compounds
12/31/2002	CA2069460C Methods and compositions for preparation and use of a herpes protease
12/30/2002	WO2002002582A1 Curcumin derivatives with improved water solubility compared to curcumin and medicaments containing the same
12/30/2002	CA2414605A1 Curcumin derivatives with improved water solubility compared to curcumin and medicaments containing the same
12/27/2002	WO2002103026A2 Method for the recombinant production of peptidic antiviral fusion inhibitors, and acetylation of gb41 fragments
12/27/2002	WO2002102999A1 Attenuated circovirus
12/27/2002	WO2002102997A2 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
12/27/2002	WO2002102975A2 Dna molecules and recombinant dna molecules for producing humanized monoclonal antibodies to s. mutans
12/27/2002	WO2002102836A2 Moraxella (branhamella) catarrhalis antigens
12/27/2002	WO2002102835A2 Novel antimicrobial compounds
12/27/2002	WO2002102829A2 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
12/27/2002	WO2002102828A2 Chimeric flavivirus vectors
12/27/2002	WO2002102825A2 Fluorescently labelled locked nucleic acids
12/27/2002	WO2002102793A2 Quinazolinediones as antibacterial agents
12/27/2002	WO2002102792A1 Novel heterocyclic antibacterial compounds
12/27/2002	WO2002102791A1 Pyrrolidine bicyclic compounds
12/27/2002	WO2002102790A1 N-formyl hydroxylamine compounds as inhibitors of pdf
12/27/2002	WO2002102787A2 Novel sulfonic acid derivatives
12/27/2002	WO2002102785A1 Novel bicyclic isoxazolinones as antibacterial agents
12/27/2002	WO2002102778A1 Phenylpyridine carbonyl piperazine derivative
12/27/2002	WO2002102766A2 Combretastatin a-3 prodrug
12/27/2002	WO2002102416A2 Antiviral glycoconjugates
12/27/2002	WO2002102410A1 Subunit vaccines and processes for the production thereof
12/27/2002	WO2002102409A1 Inactivated mycobacterial ompatb and uses thereof
12/27/2002	WO2002102404A1 Uses of cytokines
12/27/2002	WO2002102370A1 Biofilm degrading or sloughing compositions and methods
12/27/2002	WO2002102310A2 Proteins associated with cell growth, differentiation, and death
12/27/2002	WO2002102308A2 Pharmaceutical composition for the treatment of viral infection
12/27/2002	WO2002102307A2 Nucleoside vaccine adjuvants
12/27/2002	WO2002095036A3 A novel intein and uses thereof
12/27/2002	WO2002088127A3 Triazolopyrimidines
12/27/2002	WO2002085409A3 Methods and compositions for inducing an immune response to an antigen
12/27/2002	WO2002072072A3 Granules and granules coated with a masked taste
12/27/2002	WO2002069989A3 Aquatic animal treatment method and composition containing pimenta extract
12/27/2002	WO2002062335A3 Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
12/27/2002	WO2002058668A3 Artificial tear composition adapted to be used with contact lenses
12/27/2002	WO2002057302A3 A virus causing respiratory tract illness in susceptible mammals
12/27/2002	WO2002056907A3 Molecular antigen array presenting amyloid beta
12/27/2002	WO2002056874A3 Lipid-based nitric oxide donors
12/27/2002	WO2002055087B1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
12/27/2002	WO2002053142A3 Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines
12/27/2002	WO2002045746A3 Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens
12/27/2002	WO2002018445A8 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
12/27/2002	WO2002009758A3 Inhibitors of cellular efflux pumps of microbes
12/27/2002	WO2001085141A9 β-GLUCANS ENCAPSULATED IN LIPOSOMES
12/27/2002	WO2001085095B1 Chiral fluoroquinolizinone arginine salt forms
12/27/2002	WO2001011028A9 Glucuronoxylomannan (gxm)-o-acetylhydrolase of cryptococcus neoformans and uses thereof
12/27/2002	CA2455254A1 Moraxella (branhamella) catarrhalis antigens
12/27/2002	CA2450847A1 Novel compositions
12/27/2002	CA2450067A1 Proteins associated with cell growth, differentiation, and death
12/27/2002	CA2448971A1 Chimeric flavivirus vectors
12/27/2002	CA2448526A1 N-formyl hydroxylamine compounds as inhibitors of pdf
12/27/2002	CA2448506A1 Dna molecules and recombinant dna molecules for producing humanized monoclonal antibodies to s. mutans
12/27/2002	CA2448298A1 Phenylpyridine carbonyl piperazine derivative
12/27/2002	CA2446963A1 Quinazolinediones as antibacterial agents
12/27/2002	CA2446931A1 Pyrrolidine bicyclic compounds
12/27/2002	CA2430627A1 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
12/27/2002	CA2422745A1 Novel bicyclic isoxazolinones as antibacterial agents
12/27/2002	CA2418102A1 Combretastatin a-3 prodrug
12/26/2002	US20020198510 Method for nasal application of a medicinal substance
12/26/2002	US20020198509 Intradermal delivery of vaccines and gene therapeutic agents via microcannula
12/26/2002	US20020198379 Active compound from a sponge
12/26/2002	US20020198242 Administering to an animal an effective dose of atleast an enzyme Dipeptidyl Peptidase (DP IV) enzyme activity effector to increase the capacity of insulin producing cells
12/26/2002	US20020198241 Inhibiting bacterial growth in humans and nonhuman mammals by administering to the patient an antibacterially effective dose of hydroxamic acid derivatives containing carbamoyl groups
12/26/2002	US20020198224 Method for the synthesis of 2',3'-dideoxy-2',3'-didehydronucleosides
12/26/2002	US20020198219 2-pyridinamine compositions and related methods
12/26/2002	US20020198214 Such as (3-(4-(4-fluoro-benzyl)-piperidine-1-carbonyl)-4-methoxy-phenyl)-oxo-acetic acid methyl ester for proinflammation response in multiple sclerosis, inflammatory bowel disease, osteoarthritis, and other arthritic conditions
12/26/2002	US20020198206 Such as 1-Cyclohexyl-4-(4-fluorophenyl)-5-((2-phenylamino)pyrimidin-4-yl)imidazole; for use as cytokine inhibitors
12/26/2002	US20020198198 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
12/26/2002	US20020198173 Viricides for treating HIV and hepatitis virus
12/26/2002	US20020198171 Administering to a hepatitis B infection patient an effective treatment amount of a 2'fluoro- beta -D-nucleoside or salts(containing purine or pyrimidine base)
12/26/2002	US20020198168 Vaccine against Mycobacterial infections
12/26/2002	US20020198160 Compositions and methods for enhancing the bioavailability of pharmaceutical agents
12/26/2002	US20020198143 B7-like polynucleotides, polypeptides, and antibodies
12/26/2002	US20020197692 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants
12/26/2002	US20020197683 Metabolic controlled fermentation process for carbamoyl tobramycin production
12/26/2002	US20020197668 Papilloma virus capsomere vaccine formulations and methods of use
12/26/2002	US20020197667 Polypeptide for use in the treatment of thrombosis and sepsis

1 ... 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 ... 1798